Difference between revisions of "Team:DTU-Denmark/Description"

 
(67 intermediate revisions by 8 users not shown)
Line 3: Line 3:
 
<html lang="en">
 
<html lang="en">
 
<head>
 
<head>
 +
    <!-- Edited by Isabella 7-9-16 14:30 in sidebar - remove xs-hidden from sidebar -->
 +
    <!-- Edited by Isabella 26-9-16-14:22 fix white space above picture, do not edit the spaces between things this create unintentional space-->
 
     <title>Bootstrap Example</title>
 
     <title>Bootstrap Example</title>
 
     <meta charset="utf-8">
 
     <meta charset="utf-8">
Line 16: Line 18:
 
     <div class="container-fluid">
 
     <div class="container-fluid">
 
         <div class="row">
 
         <div class="row">
−
             <div class="col-md-12 thumbnail" style="background-image:url(https://www.spring-green.com/wp-content/uploads/2015/12/Tree-that-needs-pruning1.jpg)"> <!-- EDIT style url (this should lead to an image) -->
+
             <div class="col-md-12 thumbnail" style="background-image:url(https://static.igem.org/mediawiki/2016/5/56/T--DTU-Denmark--project-header.jpg)"> <!-- EDIT style url (this should lead to an image) -->
  
 
                 <div class="caption">
 
                 <div class="caption">
 
                     <div class="col-md-5 col-sm-5 col-xs-12 title"> <!-- the approximate max number of characters ~ 400 --> <!-- EDIT -->
 
                     <div class="col-md-5 col-sm-5 col-xs-12 title"> <!-- the approximate max number of characters ~ 400 --> <!-- EDIT -->
−
                         <h1>TITLE<p class="lead">leader under the title, short introduction. Ubique moderatius efficiantur eum et, dico oporteat recusabo ius cu, pro id modus sadipscing. Maluisset patrioque eum ad, mel eius doctus accommodare eu, minimum deleniti repudiandae mel ea. Noster nostrud diceret sea no. Eos an nullam molestiae signiferumque, vel ne laudem ignota oblique. Duo te luptatum percipitur signiferumque, at dicunt iriure dolorem his.</p></h1>
+
                         <h1>Parts<p class="lead">We have constructed four new basic parts, 4 composite parts, a plasmid backbone and improved two parts made by a previous team. The parts are all a part of our molecular toolbox for protein expression in <i>Yarrowia lipolytica</i>. </p></h1>
 
                     </div>
 
                     </div>
 
                     <div class="col-md-2 col-sm-2 hidden-xs space"></div>
 
                     <div class="col-md-2 col-sm-2 hidden-xs space"></div>
 
                     <div class="col-md-5 col-sm-5 hidden-xs intro"> <!-- will be hidden on phones, duplicate the text to blockquote down below first section header, to show it there, when it dissapear-->
 
                     <div class="col-md-5 col-sm-5 hidden-xs intro"> <!-- will be hidden on phones, duplicate the text to blockquote down below first section header, to show it there, when it dissapear-->
 
                         <blockquote class="blockquote-reverse"> <!-- EDIT -->
 
                         <blockquote class="blockquote-reverse"> <!-- EDIT -->
−
                             <p>Quote Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante.</p>
+
                             <p>"A great building will never stand if you neglect the small bricks"</p>
−
                             <small>Someone famous in <cite title="Source Title">Source Title</cite></small>
+
                             <small>Ifeanyi Enoch Onuoha<cite title="Source Title"></cite></small>
 
                         </blockquote>       
 
                         </blockquote>       
 
                     </div>
 
                     </div>
Line 42: Line 44:
 
     <div class="col-md-9 col-sm-10 colLeft"> <!-- LEFT -->
 
     <div class="col-md-9 col-sm-10 colLeft"> <!-- LEFT -->
 
         <div><a class="anchor" id="section-1"></a>
 
         <div><a class="anchor" id="section-1"></a>
−
        <h2 class="h2">Section 1</h2>
+
            <h2 class="h2">Parts list</h2>
 
              
 
              
 
             <blockquote class="visible-xs"> <!-- quote from masterhead duplicate -->
 
             <blockquote class="visible-xs"> <!-- quote from masterhead duplicate -->
−
                 <p>Quote Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer posuere erat a ante.</p>
+
                 <p>"A great building will never stand if you neglect the small bricks"</p>
−
                 <small>Someone famous in <cite title="Source Title">Source Title</cite></small>
+
                 <small>Ifeanyi Enoch Onuoha<cite title="Source Title"></cite></small>
 
             </blockquote>
 
             </blockquote>
 +
         
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117000">BBa_K2117000</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Constitutive TEF1 promoter</p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 
              
 
              
−
             <p>Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.
+
             <div class="grid-row">
−
             </p><p>
+
                <div class="col-md-3 col-sm-3 col-xs-12">
−
             Paragraph
+
                    <a href="http://parts.igem.org/Part:BBa_K2117001">BBa_K2117001</a>
−
             </p><p>
+
                </div>
−
             Paragraph
+
                <div class="col-md-9 col-sm-9 col-xs-12">
−
             </p>
+
                    <p>hrGFP codon-optimized for <i>Yarrowia lipolytica</i></p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 +
           
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117002">BBa_K2117002</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Composite part consisting of the TEF1 promoter and the human proinsulin gene codon-optimized for <i>Y. lipolytica</i></p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 +
           
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117003">BBa_K2117003</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Human proinsulin codon-optimized for <i>Y. lipolytica</i></p>
 +
                </div>
 +
             </div> <!-- /grid-row -->
 +
           
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117004">BBa_K2117004</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>SCR1'-tRNA promoter expressing sgRNA</p>
 +
                </div>
 +
             </div> <!-- /grid-row -->
 +
         
 +
             <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117005">BBa_K2117005</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>hrGFP expressed by the constitutive TEF1 promoter</p>
 +
                </div>
 +
             </div> <!-- /grid-row -->
 +
                       
 +
             <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117009">BBa_K2117009</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Semi-synthetic shuttle vector pSB1A8YL</p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 +
           
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117010">BBa_K2117010</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Composite part of TEF1 and enhanced YFP </p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 +
           
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117011">BBa_K2117011</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Composite part of TEF1 and enhanced CFP</p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 +
           
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Improved <a href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</a> (<em>crtE</em>)</p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 +
           
 +
            <div class="grid-row">
 +
                <div class="col-md-3 col-sm-3 col-xs-12">
 +
                    <a href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</a>
 +
                </div>
 +
                <div class="col-md-9 col-sm-9 col-xs-12">
 +
                    <p>Improved <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a>  (<em>crtI</em>)</p>
 +
                </div>
 +
            </div> <!-- /grid-row -->
 +
                     
 
         </div> <!-- /overview-->
 
         </div> <!-- /overview-->
 
          
 
          
 
         <div><a class="anchor" id="section-2"></a>
 
         <div><a class="anchor" id="section-2"></a>
−
        <h2 class="h2">Project Description</h2>
+
            <h2 class="h2">Improvement and Characterization of Two Existing Parts</h2>
−
        <h3 class="h3">Background</h3>
+
           
 
             <p>
 
             <p>
−
In Denmark today, less than half the waste produced is recycled,
+
            In our laboratory work, we wanted to work with the two BioBricks; <a href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</a> (<em>crtE</em> gene) and <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> (<em>crtI</em> gene) created by the John Hopkins iGEM team 2011. The genes encode the two enzymes Geranylgeranyl Diphosphate Synthase and Phytoene Desaturase, respectively,  both from the wildtype strain of <i>xanthophyllomyces dendrorhous</i> used in the biosynthesis of beta-Carotene.
−
which means that more than 3.5 million tons get burned off each year.
+
            </p>
−
We have abundant waste streams from the industry such as glycerol from
+
 
−
biodiesel production, byproducts from rapeseed production, used cooking
+
−
oil and ordinary household waste.
+
−
</p>
+
−
<p>
+
−
Cell factories are becoming an increasing factor in the industry today,
+
−
where different microorganisms are utilized to produce various compounds
+
−
from therapeutics, organic acids, food additives etc. Currently however,
+
−
the sustainability of these industrial processes is limited by the narrow
+
−
substrate range of the organisms used. The most common feeds in use are
+
−
simple carbohydrates such as glucose produced by enzymatic hydrolysis from
+
−
edible plants such as maize, rice and wheat.
+
−
</p>
+
−
<p>
+
−
It is widely established that the dimorphic yeast <i>Yarrowia lipolytica</i>  
+
−
grows well on a broad range of substrates such as alcohols, fatty acids,
+
−
glycerol as well as on simple sugars in complex mixtures, whereas the
+
−
conventional and widely used yeast <i>Saccharomyces cerevisiae</i> only
+
−
grows well on a very limited amount of substrates such as glucose.
+
−
Furthermore, the protein modification and secretion systems of <i>Y. lipolytica</i>  
+
−
gives rise to a higher potential as a cell factory for production of a
+
−
variety of therapeutics, food additives etc. Both of the species are fast growing,  
+
−
which contributes to the final efficiency as cell factories.
+
−
</p>
+
−
<p>
+
−
Nonetheless, <i>Y. lipolytica</i> has not been applied in industry as widely
+
−
as <i>S. cerevisiae</i> due to lack of tools for genetic engineering and as
+
−
genetic manipulation has been tedious and time consuming.
+
−
</p>
+
−
        <h3 class="h3">Methods</h3>
+
 
             <p>
 
             <p>
−
This project aims to develop the chassis for a versatile and efficient cell factory
+
            When looking into the specifications of these BioBricks, we realized that both genes contained illegal restriction sites.
−
that can transform abundant waste streams into valuable products.
+
            </p>
 +
            <p>
 +
            <a href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</a> contained an AgeI restriction site making the part incompatible with the RFC25 Freiburg Standard. The RFC25 standard allows for in-frame assembly of protein domains.
 +
            <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> contained the illegal restriction site BglII making the part incompatible with the RFC21 Berkely Standard, which enables in-frame assembly of proteins.  
 
             </p>
 
             </p>
  
−
<h3 class="h3">Methods</h3>
+
            <p>
−
<ol>
+
            We wanted to overcome these obstacle by removing the illegal restriction sites from the above described Biobricks.  
−
<li>Substrate screening</li>
+
            </p>
−
<p>
+
−
To confirm the ability of <i>Y. lipolytica</i> for efficient utilization of an impure mixture of compounds, various waste streams will be investigated as a substrate. We chose mixtures of fats, present in biodiesel waste or vegetation waters from rapeseed oil production, as well as sugars, which are present in molasses or brewery waste. In order to demonstrate the versatility of  <i>Y. lipolytica</i>, we are going even further and ferment homogenized household waste.
+
−
</p>
+
  
−
<li>Product</li>
+
            <h3 class="h3">How did we do it?</h3>
−
<p>
+
           
−
As a proof of concept we aim to demonstrate the production of both an extracellular heterologous protein and an engineered metabolite, and show how a valuable product can be produced by our cell factory utilizing waste streams.
+
            <p>
−
We will implement a codon optimized version of the human proinsulin gene along with a native <i>Y. lipolytica</i> promoter and secretion signal into <i>Y. lipolytica</i>.
+
            The illegal restriction sites were removed using site directed mutagenesis with primers containing nucleotide substitutions in the two restriction sites (see Figure 1).
−
Using an already constructed plasmid with <i>S. cerevisiae</i> optimized genes from the bacterium <i>Erwinia uredovora</i> encoding four enzymes, we will implement the biosynthesis pathway of beta-carotene in <i>Y. lipolytica</i> by using the <a href="http://parts.igem.org/Part:BBa_K152005"> K152005 biobrick</a>.
+
            </p>
−
</p>
+
 
 +
 
 +
            <figure class="figure">
 +
                <img id="img1" class="enlarge img-responsive figure-img" src="https://static.igem.org/mediawiki/2016/9/97/T--DTU-Denmark--sitedirected.png" alt="DESCRIPTION">
 +
                <figcaption class="figure-caption"><strong>Figure 1:</strong> Primers overlapping the restriction sites are designed with a single nucleotide change to disrupt the restriction site. The primers anneal to the template plasmid and replicate while introducing the point mutation. The elongated plasmids are digested with the enzyme DpnI, which cleaves at the methylated sites breaking down the circular template, resulting in a higher transformation efficiency of the linear PCR product. </figcaption>
 +
            </figure>
 +
           
 +
            <!-- The Modal with same picture-->
 +
            <div id="img1Modal" class="modal">
 +
                <span class="close img1">×</span>
 +
                <img class="modal-content" id="img1Img">
 +
                <div class="caption">DESCRIPTION</div>
 +
            </div>
 +
 
 +
 
 +
            <figure class="figure">
 +
                <img id="img2" class="enlarge img-responsive figure-img" src="https://static.igem.org/mediawiki/2016/c/cc/T--DTU-Denmark--primers.jpg" alt="DESCRIPTION">
 +
                <figcaption class="figure-caption"><strong>Table 1:</strong> Primers designed for removal of illegal restriction sites. Bold marks the nucleotide  substitution.</figcaption>
 +
            </figure>
 +
           
 +
            <!-- The Modal with same picture-->
 +
            <div id="img2Modal" class="modal">
 +
                <span class="close img2">×</span>
 +
                <img class="modal-content" id="img2Img">
 +
                <div class="caption">DESCRIPTION</div>
 +
            </div>
 +
 
 +
            <p>
 +
            The new plasmid, <a href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</a>, with the removed AgeI restriction site was double digested with the enzyme and SpeI to test if we had successfully removed the AgeI restriction site.
 +
            </p>
 +
 
 +
            <div class="row">
 +
                <div class="col-md-6 col-sm-6">
 +
                    <figure class="figure">
 +
                        <img width="400" id="img3" class="enlarge img-responsive figure-img" src="https://static.igem.org/mediawiki/2016/5/55/T--DTU-Denmark--digest1.jpg" alt="DESCRIPTION">
 +
                        <figcaption class="figure-caption"><strong>Figure 2:</strong> AgeI + SpeI digestion. Electrophoresis on a 1% agarose gel showing the digestion of  <a href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</a> (lane 1-3). <a href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</a>  digested with AgeI + SpeI and undigested <a href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</a> were used as controls (lane 4+5). </figcaption>
 +
                    </figure>
 +
                               
 +
                        <!-- The Modal with same picture-->
 +
                    <div id="img3Modal" class="modal">
 +
                        <span class="close img3">×</span>
 +
                        <img class="modal-content" id="img3Img">
 +
                        <div class="caption">DESCRIPTION</div>
 +
                    </div>
 +
                </div>
 +
                <div class="col-md-6 col-sm-6"><p style="color:transparent;">    h</p></div>
 +
            </div>
  
−
<li>Molecular toolbox</li>
 
−
<p>
 
−
This project tries to solve the lack of the well-proven tools for <i>Y. lipolytica</i>. We will develop a standardized genetic toolbox, including CRISPR/Cas9-mediated genome editing. The molecular toolbox will bring new opportunities such as an introduction of new pathways, adjusting waste utilization and targeting genetic manipulations.
 
−
</p>
 
−
</ol>
 
  
−
        </div>
 
−
       
 
−
        <div><a class="anchor" id="section-3"></a>
 
−
        <h2 class="h2">Reference tryout</h2>
 
 
             <p>
 
             <p>
−
             Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit [<a href="#references">1,4</a>]. Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.
+
             The digestion showed the removal of the AgeI restriction site, shown on the gel picture by only one band on the <a href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</a> compared to two bands on the control <a href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</a>.
−
            </p><p>
+
            </p>
−
             Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.<sup><a href="#references">2,3</a></sup> Has ut facer debitis, quo eu agam purto. In eum justo aeterno. Sea ut atqui efficiantur, mandamus deseruisse at est, erat natum cum eu. Quot numquam in vel. Salutatus euripidis moderatius qui ex, eu tempor volumus vituperatoribus has, ius ea ullum facer corrumpit.
+
 
 +
            <p>
 +
            <a href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</a> and <a href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</a>  were sent for sequencing with the verification primers VR and VF2 primers to further verify the removal of the restriction sites.  
 +
            </p>
 +
 
 +
            <div class="row">
 +
                <div class="col-md-12">
 +
                    <figure class="figure">
 +
                        <img id="img4" class="enlarge img-responsive figure-img" src="https://static.igem.org/mediawiki/2016/9/9c/T--DTU-Denmark--AgeI.JPG" alt="DESCRIPTION">
 +
                        <figcaption class="figure-caption"><strong>Figure 3:</strong> Sequencing alignment of BBa_530001 (top sequence) and  <a href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</a> (bottom sequence). The alignment shows a nucleotide substitution in the AgeI restriction site. </figcaption>
 +
                    </figure>
 +
                   
 +
                    <!-- The Modal with same picture-->
 +
                    <div id="img4Modal" class="modal">
 +
                        <span class="close img4">×</span>
 +
                        <img class="modal-content" id="img4Img">
 +
                        <div class="caption">DESCRIPTION</div>
 +
                    </div>
 +
                </div>           
 +
                           
 +
                <div class="col-md-12">
 +
                    <figure class="figure">
 +
                        <img id="img5" class="enlarge img-responsive figure-img" src="https://static.igem.org/mediawiki/2016/a/ad/T--DTU-Denmark--BglII.jpg" alt="DESCRIPTION">
 +
                        <figcaption class="figure-caption"><strong>Figure 4:</strong> Sequencing alignment of BBa_530002 (top sequence) and  <a href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</a> (bottom sequence). The alignment shows a nucleotide substitution in the BglII restriction site. </figcaption>
 +
                    </figure>
 +
                                <!-- The Modal with same picture-->
 +
                    <div id="img5Modal" class="modal">
 +
                        <span class="close img5">×</span>
 +
                        <img class="modal-content" id="img5Img">
 +
                        <div class="caption">DESCRIPTION</div>
 +
                    </div>
 +
                </div>
 +
               
 +
            </div>
 +
 
 +
 
 +
            <p>
 +
                The sequencing results show a substitution in the restriction sites corresponding to the nucleotide substitution designed in the primers (Table 1).
 +
            </p>
 +
 
 +
             <p>
 +
                By deleting the two restriction sites in the <a href="http://parts.igem.org/Part:BBa_K2117012">BBa_K2117012</a> and <a href="http://parts.igem.org/Part:BBa_K2117013">BBa_K2117013</a> we have made the two BioBricks compatible with RFC25 and RFC21 standards, respectively.
 +
            </p>
 +
 
 +
            <h3 class="h3">Improvement of Characterization</h3>
 +
 
 +
            <p>
 +
                While working with <a href="http://parts.igem.org/Part:BBa_K530001">BBa_K530001</a> and <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> we were struggling with assembly of the genes. Therefore, we sequenced the plasmids received in the distribution kit.  
 +
            </p>
 +
 
 +
            <p>
 +
                Sequencing results of <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> showed nucleotide substitutions in the prefix and a large deletion in the suffix.  
 +
            </p>
 +
 
 +
            <figure class="figure">
 +
                <img id="img6" class="enlarge img-responsive figure-img" src="https://static.igem.org/mediawiki/2016/b/b5/T--DTU-Denmark--prefix.png" alt="DESCRIPTION">
 +
                <figcaption class="figure-caption"><strong>Figure 5:</strong> Alignment of <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> sequence received from the parts page (top) and sequencing results of <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> from the distribution kit. Alignment shows many nucleotide substitutions in the prefix seuqence. </figcaption>
 +
            </figure>
 
              
 
              
−
             </p><p>
+
             <div id="img6Modal" class="modal">
−
            Paragraph
+
                <span class="close img6">×</span>
−
             </p><p>
+
                <img class="modal-content" id="img6Img">
−
            Paragraph
+
                <div class="caption">DESCRIPTION</div>
−
            </p><p>
+
             </div>
−
            Paragraph
+
 
−
            </p><p>
+
            <figure class="figure">
−
            Paragraph
+
                <img id="img7" class="enlarge img-responsive figure-img" src="https://static.igem.org/mediawiki/2016/e/e2/T--DTU-Denmark--suffix.png" alt="DESCRIPTION">
−
            </p><p>
+
                <figcaption class="figure-caption"><strong>Figure 6:</strong> Alignment of <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> sequence received from the parts page (top) and sequencing results of <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> from the distribution kit. Alignment shows a deletion in the suffix sequence. </figcaption>
−
            Paragraph
+
             </figure>
−
             </p><p>
+
              
−
             Paragraph
+
             <div id="img7Modal" class="modal">
−
             </p><p>
+
                <span class="close img7">×</span>
−
            Paragraph
+
                <img class="modal-content" id="img7Img">
−
             </p><p>
+
                <div class="caption">DESCRIPTION</div>
−
            Paragraph
+
             </div>
 +
 
 +
            <p>  
 +
                The alterations in prefix and suffix make the <a href="http://parts.igem.org/Part:BBa_K530002">BBa_K530002</a> incompatible with the BioBrick standard
 
             </p>
 
             </p>
 
         </div>
 
         </div>
−
       
+
 
−
        <div><a class="anchor" id="references"></a>
+
 
−
        <h2 class="h2">References</h2>
+
 
−
            <ol>
+
−
                <li>reference 1</li>
+
−
                <li>reference 2</li>
+
−
            </ol>
+
−
        </div>
+
 
     </div> <!-- /LEFT -->
 
     </div> <!-- /LEFT -->
−
   
 
−
   
 
 
      
 
      
 
     <!-- RIGHT-->
 
     <!-- RIGHT-->
 
     <div class="col-md-3 col-sm-2 colRight" id="scrollspy">  
 
     <div class="col-md-3 col-sm-2 colRight" id="scrollspy">  
 
         <ul class="nav" id="sidebar">
 
         <ul class="nav" id="sidebar">
−
             <li><a href="#section-1">Section 1</a></li>
+
             <li><a href="#section-1">Parts list</a></li>
−
             <li><a href="#section-2">Section 2</a></li>
+
             <li><a href="#section-2">Improvement and Characterization</a></li>
−
            <li><a href="#section-3">Section 3</a></li>
+
−
            <li><a href="#references">References</a></li>
+
−
           
+
 
         </ul>
 
         </ul>
 
     </div> <!-- /RIGHT -->
 
     </div> <!-- /RIGHT -->

Latest revision as of 02:05, 20 October 2016

New HTML template for the wiki




Bootstrap Example

Parts

We have constructed four new basic parts, 4 composite parts, a plasmid backbone and improved two parts made by a previous team. The parts are all a part of our molecular toolbox for protein expression in Yarrowia lipolytica.


Parts list

"A great building will never stand if you neglect the small bricks"

Ifeanyi Enoch Onuoha
BBa_K2117000

Constitutive TEF1 promoter

BBa_K2117001

hrGFP codon-optimized for Yarrowia lipolytica

BBa_K2117002

Composite part consisting of the TEF1 promoter and the human proinsulin gene codon-optimized for Y. lipolytica

BBa_K2117003

Human proinsulin codon-optimized for Y. lipolytica

BBa_K2117004

SCR1'-tRNA promoter expressing sgRNA

BBa_K2117005

hrGFP expressed by the constitutive TEF1 promoter

BBa_K2117009

Semi-synthetic shuttle vector pSB1A8YL

BBa_K2117010

Composite part of TEF1 and enhanced YFP

BBa_K2117011

Composite part of TEF1 and enhanced CFP

BBa_K2117012

Improved BBa_K530001 (crtE)

BBa_K2117013

Improved BBa_K530002 (crtI)

Improvement and Characterization of Two Existing Parts

In our laboratory work, we wanted to work with the two BioBricks; BBa_K530001 (crtE gene) and BBa_K530002 (crtI gene) created by the John Hopkins iGEM team 2011. The genes encode the two enzymes Geranylgeranyl Diphosphate Synthase and Phytoene Desaturase, respectively, both from the wildtype strain of xanthophyllomyces dendrorhous used in the biosynthesis of beta-Carotene.

When looking into the specifications of these BioBricks, we realized that both genes contained illegal restriction sites.

BBa_K530001 contained an AgeI restriction site making the part incompatible with the RFC25 Freiburg Standard. The RFC25 standard allows for in-frame assembly of protein domains. BBa_K530002 contained the illegal restriction site BglII making the part incompatible with the RFC21 Berkely Standard, which enables in-frame assembly of proteins.

We wanted to overcome these obstacle by removing the illegal restriction sites from the above described Biobricks.

How did we do it?

The illegal restriction sites were removed using site directed mutagenesis with primers containing nucleotide substitutions in the two restriction sites (see Figure 1).

DESCRIPTION
Figure 1: Primers overlapping the restriction sites are designed with a single nucleotide change to disrupt the restriction site. The primers anneal to the template plasmid and replicate while introducing the point mutation. The elongated plasmids are digested with the enzyme DpnI, which cleaves at the methylated sites breaking down the circular template, resulting in a higher transformation efficiency of the linear PCR product.
DESCRIPTION
Table 1: Primers designed for removal of illegal restriction sites. Bold marks the nucleotide substitution.

The new plasmid, BBa_K2117012, with the removed AgeI restriction site was double digested with the enzyme and SpeI to test if we had successfully removed the AgeI restriction site.

DESCRIPTION
Figure 2: AgeI + SpeI digestion. Electrophoresis on a 1% agarose gel showing the digestion of BBa_K2117012 (lane 1-3). BBa_K530001 digested with AgeI + SpeI and undigested BBa_K530001 were used as controls (lane 4+5).

h

The digestion showed the removal of the AgeI restriction site, shown on the gel picture by only one band on the BBa_K2117012 compared to two bands on the control BBa_K530001.

BBa_K2117012 and BBa_K2117013 were sent for sequencing with the verification primers VR and VF2 primers to further verify the removal of the restriction sites.

DESCRIPTION
Figure 3: Sequencing alignment of BBa_530001 (top sequence) and BBa_K2117012 (bottom sequence). The alignment shows a nucleotide substitution in the AgeI restriction site.
DESCRIPTION
Figure 4: Sequencing alignment of BBa_530002 (top sequence) and BBa_K2117013 (bottom sequence). The alignment shows a nucleotide substitution in the BglII restriction site.

The sequencing results show a substitution in the restriction sites corresponding to the nucleotide substitution designed in the primers (Table 1).

By deleting the two restriction sites in the BBa_K2117012 and BBa_K2117013 we have made the two BioBricks compatible with RFC25 and RFC21 standards, respectively.

Improvement of Characterization

While working with BBa_K530001 and BBa_K530002 we were struggling with assembly of the genes. Therefore, we sequenced the plasmids received in the distribution kit.

Sequencing results of BBa_K530002 showed nucleotide substitutions in the prefix and a large deletion in the suffix.

DESCRIPTION
Figure 5: Alignment of BBa_K530002 sequence received from the parts page (top) and sequencing results of BBa_K530002 from the distribution kit. Alignment shows many nucleotide substitutions in the prefix seuqence.
DESCRIPTION
Figure 6: Alignment of BBa_K530002 sequence received from the parts page (top) and sequencing results of BBa_K530002 from the distribution kit. Alignment shows a deletion in the suffix sequence.

The alterations in prefix and suffix make the BBa_K530002 incompatible with the BioBrick standard

  • FIND US AT:
Facebook Twitter
  • DTU BIOBUILDERS
  • DENMARK
  • DTU - SØLTOFTS PLADS, BYGN. 221/002
  • 2800 KGS. LYNGBY

  • E-mail:
  • dtu-biobuilders-2016@googlegroups.com
  • MAIN SPONSORS:
Lundbeck fundation DTU blue dot Lundbeck fundation Lundbeck fundation